Rare diseases
Investigational molecules
Locations
Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
GermanyComparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation
GermanyStudy of iodofalan (131I) and lomustine combination therapy compared to lomustine alone in patients with first recurrent glioblastoma
GermanyStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
GermanyStudy of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients
GermanyStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
GermanyStudy of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma
GermanyStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
GermanyStudy of pembrolizumab with drug combination for first-line treatment in patients with advanced-stage classic Hodgkin lymphoma
GermanyStudy of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy
GermanyStudy of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
